Sentinel node biopsy is reliable in early-stage cervical cancer but not in locally advanced disease.
Fiche publication
Date publication
août 2005
Journal
Annals of oncology : official journal of the European Society for Medical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles
Tous les auteurs :
Barranger E, Coutant C, Cortez A, Uzan S, Darai E
Lien Pubmed
Résumé
Sentinel lymph node (SN) biopsy based on dual labeling with blue dye and radiocolloid can reliably determine lymph node status in early-stage cervical cancer, but few data are available on its accuracy in more advanced disease. We examined the influence of tumor stage on the accuracy of SN biopsy in patients with cervical cancer.
Mots clés
Adenocarcinoma, diagnostic imaging, Adolescent, Adult, Aged, Aged, 80 and over, Carcinoma, Squamous Cell, diagnostic imaging, False Negative Reactions, Female, Humans, Laparoscopy, Lymph Node Excision, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Radionuclide Imaging, Radiopharmaceuticals, Sentinel Lymph Node Biopsy, Technetium Tc 99m Sulfur Colloid, Uterine Cervical Neoplasms, diagnostic imaging
Référence
Ann. Oncol.. 2005 Aug;16(8):1237-42